Form 8-K - Current report:
SEC Accession No. 0001104659-25-114995
Filing Date
2025-11-21
Accepted
2025-11-21 16:06:09
Documents
14
Period of Report
2025-11-18
Items
Item 5.04: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2531676d1_8k.htm   iXBRL 8-K 31514
2 EXHIBIT 99.1 tm2531676d1_ex99-1.htm EX-99.1 5184
  Complete submission text file 0001104659-25-114995.txt   254979

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abt-20251118.xsd EX-101.SCH 3368
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20251118_def.xml EX-101.DEF 28283
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20251118_lab.xml EX-101.LAB 37480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20251118_pre.xml EX-101.PRE 26507
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2531676d1_8k_htm.xml XML 5629
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 251507949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)